Gene therapy companies that could be at the center of biotech M&A
Brian Madeux, 44, looks up at nurse practitioner Jacqueline Madde while receiving the first human gene editing therapy at the UCSF Benioff Children's Hospital. Madeux, who has a metabolic disease called Hunter syndrome, will receive billions of copies of a corrective gene. Eric Risberg/AP This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Gene therapies, in which healthy genes are inserted into a person's system, are a booming biotech investment area....
Source: businessinsider.com